+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sacubitril Valsartan Sodium Drugs Market - Global Forecast to 2030- Product Image
Sacubitril Valsartan Sodium Drugs Market - Global Forecast to 2030- Product Image
New

Sacubitril Valsartan Sodium Drugs Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6079054
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Combination therapy with sacubitril valsartan sodium represents a cornerstone in modern cardiovascular care, delivering both neprilysin inhibition and angiotensin receptor blockade in one formulation. Clinicians have embraced this dual mechanism to improve morbidity and mortality outcomes among heart failure patients while expanding applications into hypertension management. Since initial regulatory approvals, real-world evidence has underscored its superior efficacy in reducing hospitalization rates and improving quality of life compared to traditional monotherapies. As health systems worldwide grapple with an aging population and rising cardiovascular disease burden, this drug’s role continues to evolve. This executive summary synthesizes the latest industry developments, policy shifts and competitive dynamics shaping the sacubitril valsartan sodium market. It provides a concise yet comprehensive framework for decision-makers seeking to understand transformative trends, the implications of emerging trade policies, and segmentation nuances that inform tailored strategies. By examining regional performance patterns and corporate strategies, this summary equips executives with actionable insights to optimize product positioning and investment decisions in a rapidly shifting landscape.

Transformative Shifts Redefining the Cardiovascular Drug Ecosystem

The sacubitril valsartan sodium market is undergoing transformative shifts driven by evolving clinical guidelines, patient-centric care models and technological innovation. Firstly, updated heart failure management protocols now endorse early initiation of combination therapy, elevating sacubitril valsartan sodium from a second-line option to a preferred first-line agent in many jurisdictions. Moreover, value-based reimbursement frameworks reward superior patient outcomes and cost savings, encouraging broader formulary inclusion. Secondly, digital health platforms and remote monitoring tools are enabling physicians to optimize dosing and adherence, creating new channels for patient engagement and real-world data collection. Meanwhile, patent expirations on legacy heart failure medications are intensifying competitive pressure, prompting branded and generic manufacturers to differentiate through novel fixed-dose combinations, patient support services and flexible packaging formats. Additionally, global health policies aimed at universal coverage are reshaping pricing and access strategies, driving manufacturers to adopt tiered pricing models and strategic partnerships in emerging markets. Consequently, stakeholders must adapt to this convergence of clinical, digital and policy forces to maintain competitive advantage and unlock new growth opportunities.

Cumulative Impact of 2025 U.S. Tariffs on API Supply Chains

In 2025, newly enacted tariffs on pharmaceutical intermediates and active pharmaceutical ingredients (APIs) in the United States have materially altered supply chain economics for sacubitril valsartan sodium. Raw material costs have risen, compelling manufacturers to reevaluate sourcing strategies and renegotiate contracts with API suppliers. As a result, production costs have increased, putting upward pressure on list prices and narrowing margin cushions. Simultaneously, distributors and wholesalers are absorbing a portion of the tariff impact to protect end-user affordability, leading to compressed channel profitability. In response, several companies have invested in near-shoring and domestic API manufacturing capabilities to mitigate future tariff volatility. This shift is reshaping global manufacturing footprints and accelerating partnerships between U.S. firms and local contract development and manufacturing organizations (CDMOs). Furthermore, some market participants are leveraging cost-containment measures, including lean manufacturing and optimized logistics, to preserve competitive pricing. Consequently, these cumulative tariff effects underscore the need for dynamic supply chain resilience and strategic procurement planning going into 2026 and beyond.

Nuanced Segmentation Insights Across Indication, Form and Patient Profile

A detailed segmentation analysis reveals multiple growth vectors within the sacubitril valsartan sodium market. By indication, demand spans heart failure and hypertension, with the former subdivided into acute presentations requiring intravenous support and chronic management geared toward long-term outpatient therapy, and the latter encompassing primary cases driven by lifestyle risk factors and secondary hypertension associated with comorbid conditions. Dosage form preferences further diversify the landscape: hard capsules and liquid-filled variants cater to patient convenience and swallowing ease, while film-coated tablets deliver controlled release and immediate-release options address rapid therapeutic needs. Patient age group segmentation highlights distinct clinical priorities; middle-aged and young adults benefit from lifestyle counseling and adherence reminders, very elderly and young elderly cohorts require simplified regimens and caregiver support, and pediatric populations ranging from adolescents to infants demand weight-based dosing and palatable formulations. End-user channels include general and specialty clinics, private and public hospitals, e-commerce and telemedicine platforms, and chain versus independent retail pharmacies, each necessitating tailored channel strategies. Condition severity drives utilization patterns, from asymptomatic or mild symptom management to ambulatory interventions for diagnostic manifestations and advanced care protocols for hospitalized patients. Marketing channels bifurcate into direct engagement via physician recommendations and field representatives, and indirect awareness building through healthcare conferences and multimedia advertising. Finally, packaging innovations span single-blister packs for dose tracking and glass or plastic bottles for bulk distribution, reflecting both patient adherence priorities and cost efficiencies.

Regional Variations Driving Tailored Market Strategies

Regional dynamics underscore varying adoption rates and strategic imperatives. In the Americas, established reimbursement systems and robust clinical awareness have fostered high penetration of sacubitril valsartan sodium in both hospital and outpatient settings, despite mounting generic competition demanding innovative patient support offerings. Europe, the Middle East and Africa present a mosaic of regulatory frameworks; centralized EMA approvals coexist with country-specific pricing negotiations and viability assessments, while emerging markets in North Africa and the Gulf region are prioritizing access through public-private partnerships and tiered procurement. In Asia-Pacific, rapid economic growth, an expanding elderly population and domestic manufacturing capabilities are driving strong volume expansion, though localized price controls and healthcare infrastructure disparities require adaptive launch strategies and targeted stakeholder engagement. These regional insights enable manufacturers to calibrate market entry, pricing and distribution models in line with distinct stakeholder expectations and policy environments.

Competitive Landscape Highlighting Key Industry Players

Competitive dynamics in the sacubitril valsartan sodium space feature a blend of established multinational innovators and agile regional players. Leading the charge are global pharmaceutical giants such as Abbott Laboratories Inc., Novartis International AG and Pfizer Inc., which leverage extensive R&D investments, broad commercialization networks and integrated patient assistance programs. Specialists in biosimilars and generics, including Alkem Laboratories Ltd., Hetero Labs Limited, Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd., are capitalizing on patent expirations to capture market share through cost-effective alternatives. Mid-sized firms like Cipla Limited, Glenmark Pharmaceuticals Ltd., Lupin Pharmaceuticals, Inc. and Zydus Cadila Healthcare Ltd. differentiate via niche formulations and emerging market focus, while Shanghai Pharmacare Ltd. and Hisun Pharmaceutical Co. Ltd. emphasize strong domestic distribution channels in China. Torrent Pharmaceuticals Ltd. and Everolimus Holdings Ltd. stand out for their flexible manufacturing partnerships with contract development and manufacturing organizations, enhancing supply chain responsiveness. This diverse competitive landscape underscores the importance of strategic alliances, differentiated value propositions and agile go-to-market models.

Actionable Recommendations for Maximizing Market Impact

To capitalize on emerging opportunities and mitigate risks, industry leaders should adopt a multifaceted strategy. First, establish robust patient support frameworks that integrate digital adherence tools, nurse helplines and personalized education to optimize clinical outcomes and drive loyalty. Second, pursue strategic partnerships with API manufacturers or local contract development organizations to secure supply resilience and cost efficiencies in light of tariff volatility. Third, invest in real-world evidence studies and pharmacoeconomic analyses to strengthen payer negotiations and demonstrate the drug’s value proposition in diverse healthcare systems. Fourth, tailor go-to-market approaches by aligning packaging formats and dosage forms with specific population segments, such as simplified blister packs for elderly patients or liquid-filled capsules for pediatric dosing. Fifth, leverage targeted communication through medical conferences, key opinion leader engagement and multichannel marketing campaigns to reinforce brand differentiation. Lastly, explore co-promotion agreements in emerging markets to accelerate penetration while sharing commercialization costs and expertise.

Concluding Insights on Strategic Imperatives

In summary, the sacubitril valsartan sodium market is characterized by accelerated clinical adoption, evolving reimbursement landscapes and competitive innovation. Stakeholders must navigate tariff-induced supply chain shifts, leverage nuanced segmentation insights and adapt region-specific strategies to sustain growth. Collaboration with payers, strategic sourcing and robust patient engagement will differentiate market leaders from fast-followers. By embracing data-driven decision-making and targeted lifecycle management, companies can optimize product value and achieve long-term success in a dynamic cardiovascular therapeutic environment.

Market Segmentation & Coverage

This research report categorizes the Sacubitril Valsartan Sodium Drugs Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Heart Failure
    • Acute Heart Failure
    • Chronic Heart Failure
  • Hypertension
    • Primary Hypertension
    • Secondary Hypertension
  • Capsule
    • Hard Capsule
    • Liquid-Filled
  • Tablet
    • Film-Coated Tablets
    • Immediate Release
  • Adult
    • Middle-Aged Adults
    • Young Adults
  • Elderly
    • Very Elderly
    • Young Elderly
  • Pediatric
    • Adolescents
    • Children
    • Infants
  • Clinics
    • General Clinics
    • Specialty Clinics
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Online Pharmacies
    • E-Commerce Platforms
    • Telemedicine Services
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Mild
    • Asymptomatic
    • Mild Symptoms
  • Moderate
    • Ambulatory
    • Diagnostic Symptoms
  • Severe
    • Advanced Care Needed
    • Hospitalized
  • Direct Marketing
    • Doctor Recommendations
    • Pharmaceutical Representatives
  • Indirect Marketing
    • Healthcare Conferences
    • Television & Online Ads
  • Blister Packs
    • Single Blister
  • Bottles
    • Glass Bottles
    • Plastic Bottles

This research report categorizes the Sacubitril Valsartan Sodium Drugs Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Sacubitril Valsartan Sodium Drugs Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories Inc.
  • Alkem Laboratories Ltd.
  • Cipla Limited
  • Everolimus Holdings Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Hisun Pharmaceutical Co. Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Shanghai Pharmacare Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila Healthcare Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sacubitril Valsartan Sodium Drugs Market, by Indication
8.1. Introduction
8.2. Heart Failure
8.2.1. Acute Heart Failure
8.2.2. Chronic Heart Failure
8.3. Hypertension
8.3.1. Primary Hypertension
8.3.2. Secondary Hypertension
9. Sacubitril Valsartan Sodium Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.2.1. Hard Capsule
9.2.2. Liquid-Filled
9.3. Tablet
9.3.1. Film-Coated Tablets
9.3.2. Immediate Release
10. Sacubitril Valsartan Sodium Drugs Market, by Patient Age Group
10.1. Introduction
10.2. Adult
10.2.1. Middle-Aged Adults
10.2.2. Young Adults
10.3. Elderly
10.3.1. Very Elderly
10.3.2. Young Elderly
10.4. Pediatric
10.4.1. Adolescents
10.4.2. Children
10.4.3. Infants
11. Sacubitril Valsartan Sodium Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Specialty Clinics
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Online Pharmacies
11.4.1. E-Commerce Platforms
11.4.2. Telemedicine Services
11.5. Retail Pharmacies
11.5.1. Chain Pharmacies
11.5.2. Independent Pharmacies
12. Sacubitril Valsartan Sodium Drugs Market, by Condition Severity
12.1. Introduction
12.2. Mild
12.2.1. Asymptomatic
12.2.2. Mild Symptoms
12.3. Moderate
12.3.1. Ambulatory
12.3.2. Diagnostic Symptoms
12.4. Severe
12.4.1. Advanced Care Needed
12.4.2. Hospitalized
13. Sacubitril Valsartan Sodium Drugs Market, by Marketing Channel
13.1. Introduction
13.2. Direct Marketing
13.2.1. Doctor Recommendations
13.2.2. Pharmaceutical Representatives
13.3. Indirect Marketing
13.3.1. Healthcare Conferences
13.3.2. Television & Online Ads
14. Sacubitril Valsartan Sodium Drugs Market, by Packaging
14.1. Introduction
14.2. Blister Packs
14.2.1. Single Blister
14.3. Bottles
14.3.1. Glass Bottles
14.3.2. Plastic Bottles
15. Americas Sacubitril Valsartan Sodium Drugs Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Sacubitril Valsartan Sodium Drugs Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories Inc.
18.3.2. Alkem Laboratories Ltd.
18.3.3. Cipla Limited
18.3.4. Everolimus Holdings Ltd.
18.3.5. Glenmark Pharmaceuticals Ltd.
18.3.6. Hetero Labs Limited
18.3.7. Hisun Pharmaceutical Co. Ltd.
18.3.8. Lupin Pharmaceuticals, Inc.
18.3.9. Novartis International AG
18.3.10. Pfizer Inc.
18.3.11. Shanghai Pharmacare Ltd.
18.3.12. Sun Pharmaceutical Industries Ltd.
18.3.13. Teva Pharmaceutical Industries Ltd.
18.3.14. Torrent Pharmaceuticals Ltd.
18.3.15. Zydus Cadila Healthcare Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET MULTI-CURRENCY
FIGURE 2. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CHRONIC HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PRIMARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SECONDARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY LIQUID-FILLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY FILM-COATED TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY VERY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY YOUNG ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TELEMEDICINE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ASYMPTOMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD SYMPTOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY AMBULATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIAGNOSTIC SYMPTOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADVANCED CARE NEEDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOCTOR RECOMMENDATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PHARMACEUTICAL REPRESENTATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEALTHCARE CONFERENCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TELEVISION & ONLINE ADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SINGLE BLISTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 161. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 163. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 164. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 165. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 166. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 167. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 169. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 170. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 171. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 175. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 176. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 177. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 178. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 179. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 180. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 182. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 183. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 184. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 185. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 186. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 188. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 189. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 190. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 191. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 192. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 204. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 205. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 207. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 208. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 209. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CONDITION SEVERITY, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MILD, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MODERATE, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY SEVERE, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY MARKETING CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDIRECT MARKETING, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 288. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 290. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 291. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 292. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 293. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 294. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 295. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 296. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 297. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 298. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 300. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 303. CHINA SACUBITRI

Companies Mentioned

  • Abbott Laboratories Inc.
  • Alkem Laboratories Ltd.
  • Cipla Limited
  • Everolimus Holdings Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Hisun Pharmaceutical Co. Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Shanghai Pharmacare Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila Healthcare Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chronic Heart Failure - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Chronic Heart Failure - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 331 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Myocardial Infarction Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Myocardial Infarction Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.